Immunic, Inc. (IMUX)
USD 1.03
(-5.5%)
USD 1.03
(-5.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -70.82 Million | -65.14 Million | -83.23 Million | -46.12 Million | -28.54 Million | -43.16 Million |
| Net Income | -93.61 Million | -120.4 Million | -92.94 Million | -44.01 Million | -34.93 Million | -41.47 Million |
| Depreciation & Amortization | 111 Thousand | 77 Thousand | 85 Thousand | 39 Thousand | 50 Thousand | 727 Thousand |
| Deferred income taxes | -817 Thousand | - | 4.33 Million | - | -355 Thousand | 1.21 Million |
| Stock-based compensation | 7102.00 | 7.92 Million | 5.94 Million | 2.74 Million | 6.51 Million | 3.73 Million |
| Change in working capital | 15.04 Million | 9.53 Million | -9.27 Million | -2.36 Million | -1.35 Million | -7.6 Million |
| Other non-cash items | 1.34 Million | 37.72 Million | 8.62 Million | -2.52 Million | 1.54 Million | 234 Thousand |
| Investing Cash Flow | 9.46 Million | -9.74 Million | -67 Thousand | -146 Thousand | 10.53 Million | -415 Thousand |
| Investments in PPE | -334 Thousand | -112 Thousand | -67 Thousand | -146 Thousand | -55 Thousand | -597 Thousand |
| Acquisitions | - | - | - | - | 10.66 Million | - |
| Investment purchases | 9.79 Million | -9.62 Million | - | - | - | - |
| Sales/Maturities of investments | 9.79 Million | - | - | - | - | - |
| Other Investing Activities | -9.79 Million | -9629.00 | - | - | -75 Thousand | 182 Thousand |
| Financing Cash Flow | 1033.00 | 95.76 Thousand | 42.84 Thousand | 144.43 Million | 34.89 Million | 4000.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 129 Thousand | 182 Thousand | 92 Thousand | - | - | - |
| Common Stock Issuance | 1.03 Million | 95.76 Million | 42.84 Million | 144.43 Million | 35.16 Million | 115 Thousand |
| Other Financing Activities | 1033.00 | 95.76 Thousand | 42.84 Thousand | 144.43 Thousand | -270 Thousand | -111 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 817 Thousand | 799 Thousand | 176 Thousand | 1 Million | -462 Thousand | -770 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 14.23 Million | 8.73 Million | -9.45 Million | -3.36 Million | -897 Thousand | -6.83 Million |
| Cash at beginning of period | 106.74 Million | 86.86 Million | 127.45 Million | 29.36 Million | 13.07 Million | 56.9 Million |
| Cash at end of period | 46.67 Million | 106.74 Million | 86.86 Million | 127.45 Million | 29.36 Million | 13.32 Million |
| Capital Expenditure | -334 Thousand | -112 Thousand | -67 Thousand | -146 Thousand | -55 Thousand | -597 Thousand |
| Effect of forex changes on cash | 262 Thousand | -993 Thousand | -130 Thousand | -78 Thousand | -589 Thousand | -1000.00 |
| Net cash flow / Change in cash | -60.07 Million | 19.88 Million | -40.58 Million | 98.08 Million | 16.29 Million | -43.57 Million |
| Free Cash Flow | -71.16 Million | -65.25 Million | -83.3 Million | -46.27 Million | -28.6 Million | -43.76 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -21.38 Million | -29.58 Million | -93.61 Million | -21.57 Million | -22.76 Million | -23.99 Million |
| Depreciation & Amortization | 31 Thousand | 26 Thousand | 111 Thousand | 23 Thousand | 34 Thousand | 22 Thousand |
| Deferred income taxes | - | - | -817 Thousand | 84 Thousand | - | - |
| Stock-based compensation | 1882.00 | 2.75 Million | 7.1 Million | 1.63 Million | 1.68 Million | 1.79 Million |
| Change in working capital | 2.92 Million | -3.98 Million | 15.04 Million | 6.07 Million | 3.68 Million | 2.05 Million |
| Other non-cash items | 274 Thousand | 7.83 Million | 1.34 Million | -273 Thousand | 47 Thousand | 149 Thousand |
| Investing Cash Flow | -180 Thousand | -31 Thousand | 9.46 Million | -165 Thousand | -44 Thousand | 4.33 Million |
| Investments in PPE | -180 Thousand | -31 Thousand | -334 Thousand | -165 Thousand | -44 Thousand | -21 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | 9.79 Million | 9.79 Million | - | - |
| Sales/Maturities of investments | - | - | 9.79 Million | -9.79 Million | - | 4.35 Million |
| Other Investing Activities | - | - | -9.79 Million | - | - | 4357.00 |
| Financing Cash Flow | - | 74.46 Million | 1033.00 | 604.00 | 282.00 | 96.00 |
| Debt repayment | - | -74.27 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 129 Thousand | 129 Thousand | - | - |
| Common Stock Issuance | - | 191 Thousand | 1.03 Million | 604 Thousand | 282 Thousand | 96 Thousand |
| Other Financing Activities | - | 74.27 Million | 1033.00 | 604.00 | 282.00 | 96.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.18 Million | 1.79 Million | 817 Thousand | 1.76 Million | -1.4 Million | -537 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.74 Million | -5.78 Million | 14.23 Million | 4.3 Million | 5.08 Million | 2.59 Million |
| Cash at beginning of period | 97.31 Million | 46.67 Million | 106.74 Million | 59.68 Million | 77.29 Million | 92.76 Million |
| Cash at end of period | 79.69 Million | 97.31 Million | 46.67 Million | 46.67 Million | 59.68 Million | 77.29 Million |
| Capital Expenditure | -180 Thousand | -31 Thousand | -334 Thousand | -165 Thousand | -44 Thousand | -21 Thousand |
| Effect of forex changes on cash | -403 Thousand | 174 Thousand | 262 Thousand | 573 Thousand | -531 Thousand | 77 Thousand |
| Net cash flow / Change in cash | -17.61 Million | 50.63 Million | -60.07 Million | -13.01 Million | -17.6 Million | -15.46 Million |
| Free Cash Flow | -17.21 Million | -24 Million | -71.16 Million | -14.19 Million | -17.35 Million | -19.99 Million |
601688
6634
EGBN
7713
600195
APS